• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchKinnate Biopharma
    Picture of Kinnate Biopharma logo

    KNTE — Kinnate Biopharma News Story

    $2.660.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    • Market Cap
      $125.62m
    • Enterprise Value
      -$28.41m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • KNTE Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    KNTE Dividends
    All News

    NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:01 AM

    Picture of Kinnate Biopharma logoKinnate Biopharma
    03/12/2020 09:01
    NASDAQ TRADE HALT  KNTE.O  REASON NOT AVAILABLE AT 04:01 AM
    

    Recent news on Kinnate Biopharma

    See all news
    • Kinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary

      29/03/2024 19:05
    • Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview

      22/03/2024 21:04
    • Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc

      19/03/2024 20:17
    • Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview

      15/03/2024 21:25
    • Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview

      11/03/2024 20:51

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.